XML 24 R17.htm IDEA: XBRL DOCUMENT v3.25.3
Business Segment Information
 9 Months Ended
Nov. 01, 2025
Segment Reporting [Abstract]  
Business Segment Information

Note 8

Business Segment Information

 

Three Months Ended November 1, 2025

 

 

 

 

 

 

(In thousands)

Journeys
Group

Schuh
Group

Johnston
& Murphy
Group

Genesco Brands Group

Corporate
& Other

Consolidated

Sales

$376,707

$123,766

$81,157

$34,587

$—

$616,217

Intercompany sales elimination

—

—

—

—

—

—

Net sales to external customers(1)

376,707

123,766

81,157

34,587

—

616,217

Cost of sales

190,436

72,095

38,207

26,851

—

327,589

Gross margin

186,271

51,671

42,950

7,736

—

288,628

Selling and administrative expenses

165,705

51,002

43,545

7,195

8,273

275,720

Segment operating income (loss)

20,566

669

(595)

541

(8,273)

12,908

Asset impairments and other(2)

—

—

—

—

4,332

4,332

Operating income (loss)

20,566

669

(595)

541

(12,605)

8,576

Other components of net periodic benefit cost

—

—

—

—

149

149

Interest expense, net

—

—

—

—

884

884

Earnings (loss) from continuing operations before income taxes

$20,566

$669

$(595)

$541

$(13,638)

$7,543

Total assets (3)

$826,248

$226,909

$212,920

$57,107

$148,919

$1,472,103

Depreciation and amortization

8,258

2,054

1,783

349

917

13,361

Capital expenditures

12,637

1,547

4,096

60

265

18,605

 

(1) Net sales in North America and in the U.K., which includes the ROI, accounted for 80% and 20%, respectively, of our net sales in the third quarter of Fiscal 2026.

(2) Asset impairments and other includes a $3.9 million charge for store restructuring, including $3.6 million in Journeys Group and $0.3 million in Schuh Group, $0.2 million for severance and $0.2 million for asset impairments in Schuh Group.

(3) Of our $721.3 million of long-lived assets as of November 1, 2025, $91.1 million and $14.6 million relate to long-lived assets in the U.K. and Canada, respectively.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Note 8

Business Segment Information, Continued

 

Three Months Ended November 2, 2024

 

 

 

 

 

 

(In thousands)

Journeys
Group

Schuh
Group

Johnston
& Murphy
Group

Genesco Brands Group

Corporate
& Other

Consolidated

Sales

$362,517

$121,826

$78,463

$33,587

$—

$596,393

Intercompany sales elimination

—

—

—

(65)

—

(65)

Net sales to external customers(1)

362,517

121,826

78,463

33,522

—

596,328

Cost of sales

184,068

69,477

35,895

21,632

—

311,072

Gross margin

178,449

52,349

42,568

11,890

—

285,256

Selling and administrative expenses

165,283

49,230

42,659

8,161

9,579

274,912

Segment operating income (loss)

13,166

3,119

(91)

3,729

(9,579)

10,344

Asset impairments and other (2)

—

—

—

—

134

134

Operating income (loss)

13,166

3,119

(91)

3,729

(9,713)

10,210

Other components of net periodic benefit cost

—

—

—

—

86

86

Interest expense, net

—

—

—

—

1,213

1,213

Earnings (loss) from continuing operations before income taxes

$13,166

$3,119

$(91)

$3,729

$(11,012)

$8,911

Total assets (3)

$746,432

$215,531

$178,166

$69,478

$225,914

$1,435,521

Depreciation and amortization

8,385

1,944

1,358

337

1,030

13,054

Capital expenditures

6,255

3,109

3,561

108

90

13,123

 

(1) Net sales in North America and in the U.K., which includes the ROI, accounted for 80% and 20%, respectively, of our net sales for the third quarter of Fiscal 2025.

(2) Asset impairments and other includes a $0.1 million charge for asset impairments in Journeys Group.

(3) Of our $655.0 million of long-lived assets as of November 2, 2024, $93.7 million and $9.8 million relate to long-lived assets in the U.K. and Canada, respectively.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Note 8

Business Segment Information, Continued

 

Nine Months Ended November 1, 2025

 

 

 

 

 

 



(In thousands)

Journeys
Group

Schuh
Group

Johnston
& Murphy
Group

Genesco Brands Group

Corporate
& Other

Consolidated

Sales

$967,530

$346,276

$226,785

$95,564

$—

$1,636,155

Intercompany sales elimination

—

—

—

—

—

—

Net sales to external customers(1)

967,530

346,276

226,785

95,564

—

1,636,155

Cost of sales

492,712

207,245

105,540

70,900

—

876,397

Gross margin

474,818

139,031

121,245

24,664

—

759,758

Selling and administrative expenses

474,534

144,504

123,122

22,772

24,088

789,020

Segment operating income (loss)

284

(5,473)

(1,877)

1,892

(24,088)

(29,262)

Asset impairments and other(2)

—

—

—

—

4,747

4,747

Operating income (loss)

284

(5,473)

(1,877)

1,892

(28,835)

(34,009)

Other components of net periodic benefit cost

—

—

—

—

477

477

Interest expense, net

—

—

—

—

3,682

3,682

Earnings (loss) from continuing
   operations before income taxes

$284

$(5,473)

$(1,877)

$1,892

$(32,994)

$(38,168)

Depreciation and amortization

$24,841

$6,107

$5,263

$1,037

$2,980

$40,228

Capital expenditures

30,739

7,521

13,104

200

621

52,185

 

(1) Net sales in North America and in the U.K., which includes the ROI, accounted for 79% and 21%, respectively, of our net sales for the first nine months of Fiscal 2026.

(2) Asset impairments and other includes a $3.9 million charge for store restructuring, including $3.6 million in Journeys Group and $0.3 million in Schuh Group, $0.6 million for severance and $0.2 million for asset impairments in Schuh Group.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Note 8

Business Segment Information, Continued

 

Nine Months Ended November 2, 2024

 

 

 

 

 

 



(In thousands)

Journeys
Group

Schuh
Group

Johnston
& Murphy
Group

Genesco Brands Group

Corporate
& Other

Consolidated

Sales

$920,808

$338,736

$228,707

$88,941

$—

$1,577,192

Intercompany sales elimination(1)

—

—

—

1,921

—

1,921

Net sales to external customers(2)

920,808

338,736

228,707

90,862

—

$1,579,113

Cost of sales

469,486

195,777

106,277

60,397

—

831,937

Gross margin

451,322

142,959

122,430

30,465

—

747,176

Selling and administrative expenses

468,129

138,397

120,569

25,050

25,733

777,878

Segment operating income (loss)

(16,807)

4,562

1,861

5,415

(25,733)

(30,702)

Asset impairments and other(3)

—

—

—

—

1,490

1,490

Operating income (loss)

(16,807)

4,562

1,861

5,415

(27,223)

(32,192)

Other components of net periodic benefit cost

—

—

—

—

281

281

Interest expense

—

—

—

—

3,448

3,448

Earnings (loss) from continuing
   operations before income taxes

$(16,807)

$4,562

$1,861

$5,415

$(30,952)

$(35,921)

Depreciation and amortization

$25,545

$5,662

$4,136

$982

$3,135

$39,460

Capital expenditures

14,059

5,606

6,737

643

352

27,397

 

(1) Intercompany sales for the first nine months of Fiscal 2025 reflect net intercompany returns.

(2) Net sales in North America and in the U.K., which includes the ROI, accounted for 79% and 21% respectively, of our net sales for the first nine months of Fiscal 2025.

(3) Asset impairments and other includes a $0.5 million charge for asset impairments in Journeys Group and $1.0 million for severance.